| Cardiologist agrees to $5.8M settlement for implanting dozens of unnecessary stents |
| Energy drink consumption triggers high BP, electrical abnormalities in heart |
| Survey: Nearly half of hypertensives unworried about future CV events |
| Proton pump inhibitors linked to fatal cases of CVD, CKD, stomach cancer |
| FDA fast-tracks new CV indication for Vascepa |
| Ultra-processed foods threaten CV health in Western countries |
| Fasting before cholesterol labs is futile, researchers say |
| COAPT: Patients with HF, mitral regurgitation see better health outcomes with TMVR |
| Heart attack victims wait an average of 3 hours to get help—here’s why |
| AFib market expected to reach $14.7B by 2026 |
| Some e-cig flavors could be more toxic than others |
| Millennials less heart-healthy than Gen Xers at the same age |
| Some Canadians waiting more than a year for elective echos |
| Fertility treatment linked to peripartum cardiomyopathy |
| Immigrant with heart failure, CAD deported without adequate access to healthcare |
| ACC names 1st-ever director of diversity and inclusion |
| Veterans with PTSD, depression more likely to participate in cardiac rehab |
| 1st live transmission of robotic PCI performed in Europe |
| Women less likely to be resuscitated than men during OHCA |
| Andrea Russo inducted as HRS president |
| Study suggests MRI should be standard practice for NSTEMI diagnosis, treatment |
| More than ⅔ of cardiovascular RCT reports skew language to reflect better outcomes |
| Orsiro achieves lower target lesion failure, revascularization than thicker stents |
| New guidelines redefine cardiogenic shock |
| Abiomed’s Impella RP system is safe, FDA says |
| Antibacterial envelope cuts risk of CIED infection by 40% |
| How to alleviate patient anxiety about ICDs |
| Abbott’s tricuspid valve repair system finds success in TRILUMINATE study |
| Algorithm optimizes catheter ablation in AFib patients |
| Dabigatran no more effective than aspirin for recurrent stroke prevention |
| For teens, being overweight is just as risky as being obese |
| Grapefruit juice prolongs patients’ QT interval |
| Myocardial injury commonly miscoded as type 2 MI |
| Early gastric bypass improves odds of diabetes remission in teens |
| T-cells in arterial plaque could signal stroke risk |
| FDA approves 1st anticoagulant for use in pediatric patients |
| ICDs are underused in clinical practice—especially in women and minorities |
| More than ⅓ of statin patients fail to achieve healthy LDL-C |
| First personal 6-lead ECG cleared for sale in US |
| Arthritic pain reliever glucosamine cuts risk of CVD death by 22% |
| Federal judge: Illegal actions by FDA fueled e-cig epidemic |
| New rule allows physicians to refuse care on grounds of religious, moral beliefs |
| Azithromycin ‘Z-packs’ tied to potentially fatal arrhythmia |
| Generic equivalent of Pfizer hypertension drug approved |
| Risk of low-dose aspirin outweighs benefit in general population |
| How AI could prevent unnecessary testing in patients with chest pain |
| CV deaths in the UK trending up for 1st time in 50 years |
| HRS releases consensus statement on arrhythmogenic cardiomyopathy: 5 things to know |
| Algorithm tops physicians in predicting heart attacks, death |
| Bioengineered blood vessels could replace vasculature damaged by renal failure, CVD |
| Researchers developing AI-powered ‘smart ring’ to detect AFib |
| How cardiologists reacted to the rapid rise and fall of BVS |
| Positive Projections: TAVR/TMVR Market Likely to Double by 2023 |
| Making the Case for Cardiac PET: Before Buying in, Evaluate Clinical & Business Considerations |
| Stop the Bleeding: Hemorrhagic Complications Gain Ground on Ischemia in Treating Patients with Arrhythmia |
| The Opioid Crisis May Be Coming to Your Cardiology Practice |
| Challenges of Infective Endocarditis: The Opioid Crisis Hits Home & Cardiologists Can’t Go It Alone |
| From Concept to Clearance: Why It’s So Expensive to Develop New CV Drugs |
| Going the Distance: Is Telestenting a New Path for PCI? |
| ‘Really Not Close’: TAVR Trumps SAVR in Two Trials of Low-risk Patients |
| BioCardia receives clearance for AVANCE steerable catheter introducers |
| Study reveals patients don’t know much about their heart implants—but they want to |
| Antiglycemic agent tied to 55 cases of life-threatening gangrene in diabetics |
| More young people in the US are dying from HF-related CVD |
| CVD in pregnancy the leading cause of death among US mothers |
| Diabetic ketoacidosis more widespread in the US than Canada |
| UGA researchers find 27 new metabolites tied to arterial stiffness |
| FDA: Certain Medtronic pacemaker, CRT-P batteries can fail without warning |
| CRT vs. RV pacing: Which is better for HFpEF patients? |
| Preemie heart damage could be reversed with exercise in young adulthood |
| Arsenic in drinking water linked to LV thickening, hypertrophy |
| Biotech startup aims to eradicate CAD with gene editing |
| FDA OKs Pfizer’s tafamidis to treat cardiac amyloidosis |
| Migraine drug shows no increase in CV outcomes |
| ARB update: Vivimed issues 19-lot recall of losartan |
| Weighing the plausibility of a genetic test for predicting obesity |
| Prolonged exposure to low-dose radiation elevates risk of hypertension |
| Unnecessary procedures cost Kentucky cardiologist $1M, 5 years in prison |
| Oral infections during childhood linked to CVD later in life |
| CABG trumps PCI in multivessel CAD patients |
| Live in Las Vegas: SCAI.19 Expands Focus on Live Cases |
| AFib gadget packs BP monitor, ECG into singular device |
| STEMI DTU trial greenlighted by the FDA |
| AHA backs federal efforts to raise tobacco sale age to 21 |
| Sex-specific VIRGO taxonomy better classifies women with MI |
| Physicians often overlook statin guidelines for ASCVD patients |
| Losartan recall grows by another 35 lots |
| FDA clears world’s 1st active-fixation left heart lead |
| Viagra-like sex drug also effective as HF therapy |
